logo

Akebia Therapeutics Inc. Inc. (AKBA) Price Performance: A Comparative Analysis with Competitors

CROX

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant loss of -12.90% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -31.21%. Over the past 30 days, the price of AKBA has fallen by 1.89%. And in the last five days, it has surged by 12.50%.

The stock market performance of Akebia Therapeutics Inc. has been fairly unsteady. Over the last year, the company’s stock hit its highest at $2.48 on 03/28/24, while the lowest price during the same time frame was $0.78, recorded on 10/26/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

52-week price history of AKBA Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Akebia Therapeutics Inc.’s current trading price is -56.45% away from its 52-week high, while its distance from the 52-week low is 38.44%. The stock’s price range over this timeframe has been between $0.78 and $2.48. The shares of the Healthcare sector company recorded a trading volume of approximately 1.81 million for the day, which was comparatively lower than the average daily volume of 3.3 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Akebia Therapeutics Inc. (AKBA) has experienced a quarterly decline of -29.87% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 226.37M and boasts a workforce of 167 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.3433, with a change in price of -0.4500. Similarly, Akebia Therapeutics Inc. recorded 4,478,251 in trading volume during the last 100 days, posting a change of -29.41%.

AKBA Stock Stochastic Average

The raw stochastic average for Akebia Therapeutics Inc. over the last 50 days is presently at 36.84%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 70.89%. Further, the company’s Stochastic %K and %D values for the last 20 days were 51.07% and 42.09%, respectively.

Most Popular